Abstract

ObjectiveTo evaluate the feasibility and efficacy of total parathyroidectomy followed by modified needle-quantified injection of parathyroid autograft compared with classic incision and transplantation. MethodsWe conducted a retrospective study of 171 patients with secondary hyperparathyroidism treated by hemodialysis or peritoneal dialysis. These patients were included in our study from April 2006 to December 2016, who had undergone total parathyroidectomies with autotransplantation. Patients were divided into classic incision for transplantation of parathyroid autograft group and modified needle-quantified injection group. Clinical and biochemical characteristics, including preoperative and postoperative intact parathyroid hormone levels were recorded and compared between two group patients. ResultsTo compare the techniques of modified needle-quantified injection and classic incision and transplantation, pre- and postoperative biochemistry and length of operation was recorded and analyzed. Preoperative biochemistry was similarly in both groups. However, autograft function achieved was significantly faster in the group with modified needle-quantified injection compared with classic incision and transplantation (P = 0.03). Median time to parathyroid function regain was 3 months for injection compared with 7 months for classic incision. There was no remarkable difference in the recurrence rates between the two groups. ConclusionThe modified needle-quantified injection of parathyroid tissue is a feasible and simple alternative to the more commonly used method of classic incision and transplantation.

Highlights

  • We conducted a retrospective study of 171 patients with secondary hyperparathyroidism treated by hemodialysis or peritoneal dialysis

  • Autograft function achieved was significantly faster in the group with modified needle-quantified injection compared with classic incision and transplantation (P = 0.03)

  • Secondary hyperparathyroidism (SHPT) is one of the most common clinical problems faced by chronic kidney disease (CKD) patients with long-term dialysis

Read more

Summary

Introduction

Secondary hyperparathyroidism (SHPT) is one of the most common clinical problems faced by chronic kidney disease (CKD) patients with long-term dialysis. This disease may even lead to a significant increase in all-cause death and cardiovascular death in patients, which seriously affects their quality of life[1]. As increase of patients age, calcium and phosphorus metabolism disorders, patients with poor response to drug and general treatment often progress to refractory SHPT. These patients eventually need to undergo parathyroid surgery. The purpose of this retrospective study was to analyze the feasibility and effectiveness of this innovative approach of parathyroid transplantation

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call